Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Penumbra, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference

Posted on: 26 Jul 17

ALAMEDA, Calif., July 25, 2017 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 37th Annual Growth Conference in Boston, MA on Wednesday, August 9, 2017. 


Canaccord Genuity 37th Annual Growth Conference


Wednesday, August 9, 2017


2:00pm ET / 11:00am PT

A webcast of the presentation will be available by visiting the investors section of the company's website at The webcast will be available on the company's website for two weeks following the event.

About Penumbra

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on interventional therapies. Penumbra designs, develops, manufactures and markets innovative devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a registered trademark of Penumbra, Inc.

Investor Relations

Penumbra, Inc.

Editor's Details

Mike Wood

Last updated on: 26/07/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.